VOR
VOR
US9290332074
Vor Biopharma Inc.
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue -- --
--
Cost of Revenue -- --
--
Gross Profit -- --
--
371.642.000 121.185.000
206.7%
Operating Income -371.642.000 -121.185.000
206.7%
Pretax Income -695.981.000 -116.914.000
495.3%
Net Income Common Stockholders -695.981.000 -116.914.000
495.3%
-- --
--
-- --
--
ende